Anticancer agent 232
Product Specifications
Target
Endogenous Metabolite
Related Pathways
Metabolism
Bioactivity
Anticanceragent 232 (compound 12f) is a sugar hybrid designed from 1-azide glycosides derived from d-glucose, d-galactose, and d-mannose. The IC50 values for this compound are 1.05 μM against MCF-7 cells and 18.03 μM for MDA-MB231 cells.
Molecular Formula
C32H31BrN4O11
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1144867-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Transcription factor IIIA (PZF1)
Sign In for Pricing
View Details MBS1144867-02 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Transcription factor IIIA (PZF1)
Sign In for Pricing
View Details MBS1144867-03 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Transcription factor IIIA (PZF1)
Sign In for Pricing
View Details MBS1144867-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Transcription factor IIIA (PZF1)
Sign In for Pricing
View Details MBS1144867-05 0.02 mg (Baculovirus)
Recombinant Saccharomyces cerevisiae Transcription factor IIIA (PZF1)
Sign In for Pricing
View Details MBS1144867-06 0.02 mg (Mammalian-Cell)
Recombinant Saccharomyces cerevisiae Transcription factor IIIA (PZF1)
Sign In for Pricing
View Details